Edwards Lifesciences Corp

XNYS:EW

86.47

+0.51 (+0.59%)

6:55:55 PM EDT: $87.00 +0.53 (+0.61%)

Market Cap (Intraday)	49.79B
Current PE	46.29
Forward PE	28.73
2yr Forward PE	25.66

See more stats

Estimates Current Quarter

Revenue	$1.7 Billion
Adjusted EPS	$0.74

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Edwards Lifesciences Corp Stock, XNYS:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 15800

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.